436 related articles for article (PubMed ID: 19027780)
21. [Detection of gene mutations of SCN5A in 7 patients with Brugada syndrome].
Yuan BB; Shan QJ; Yang B; Chen ML; Zou JG; Chen C; Xu DJ; Cao KJ
Zhonghua Xin Xue Guan Bing Za Zhi; 2008 May; 36(5):404-7. PubMed ID: 19100032
[TBL] [Abstract][Full Text] [Related]
22. Sodium channelopathies: do we really understand what's going on?
Postema PG; Mosterd A; Hofman N; Alders M; Wilde AA
J Cardiovasc Electrophysiol; 2011 May; 22(5):590-3. PubMed ID: 20812931
[TBL] [Abstract][Full Text] [Related]
23. Mutation-specific effects of lidocaine in Brugada syndrome.
Clancy CE; Wehrens XH
Int J Cardiol; 2007 Oct; 121(3):249-52. PubMed ID: 17761312
[TBL] [Abstract][Full Text] [Related]
24. A sodium channel pore mutation causing Brugada syndrome.
Pfahnl AE; Viswanathan PC; Weiss R; Shang LL; Sanyal S; Shusterman V; Kornblit C; London B; Dudley SC
Heart Rhythm; 2007 Jan; 4(1):46-53. PubMed ID: 17198989
[TBL] [Abstract][Full Text] [Related]
25. Cardiac sodium channelopathies.
Amin AS; Asghari-Roodsari A; Tan HL
Pflugers Arch; 2010 Jul; 460(2):223-37. PubMed ID: 20091048
[TBL] [Abstract][Full Text] [Related]
26. Overlap syndrome of cardiac sodium channel disease in mice carrying the equivalent mutation of human SCN5A-1795insD.
Remme CA; Verkerk AO; Nuyens D; van Ginneken AC; van Brunschot S; Belterman CN; Wilders R; van Roon MA; Tan HL; Wilde AA; Carmeliet P; de Bakker JM; Veldkamp MW; Bezzina CR
Circulation; 2006 Dec; 114(24):2584-94. PubMed ID: 17145985
[TBL] [Abstract][Full Text] [Related]
27. Cardiac sodium channel dysfunction in sudden infant death syndrome.
Wang DW; Desai RR; Crotti L; Arnestad M; Insolia R; Pedrazzini M; Ferrandi C; Vege A; Rognum T; Schwartz PJ; George AL
Circulation; 2007 Jan; 115(3):368-76. PubMed ID: 17210841
[TBL] [Abstract][Full Text] [Related]
28. The cardiac sodium channel: gating function and molecular pharmacology.
Balser JR
J Mol Cell Cardiol; 2001 Apr; 33(4):599-613. PubMed ID: 11273715
[TBL] [Abstract][Full Text] [Related]
29. [Novel SCN5A gene mutations associated with Brugada syndrome: V95I, A1649V and delF1617].
Liang P; Liu WL; Hu DY; Li CL; Tao WH; Li L
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jul; 34(7):616-9. PubMed ID: 17081365
[TBL] [Abstract][Full Text] [Related]
30. A paradoxical effect of lidocaine for the N406S mutation of SCN5A associated with Brugada syndrome.
Itoh H; Tsuji K; Sakaguchi T; Nagaoka I; Oka Y; Nakazawa Y; Yao T; Jo H; Ashihara T; Ito M; Horie M; Imoto K
Int J Cardiol; 2007 Oct; 121(3):239-48. PubMed ID: 17445919
[TBL] [Abstract][Full Text] [Related]
31. Clinical heterogeneity in sodium channelopathies. What is the meaning of carrying a genetic mutation?
Oliva A; Bjerregaard P; Hong K; Evans S; Vernooy K; McCormack J; Brugada J; Brugada P; Pascali VL; Brugada R
Cardiology; 2008; 110(2):116-22. PubMed ID: 17971661
[TBL] [Abstract][Full Text] [Related]
32. Sudden cardiac death and inherited arrhythmia syndromes.
Sarkozy A; Brugada P
J Cardiovasc Electrophysiol; 2005 Sep; 16 Suppl 1():S8-20. PubMed ID: 16138889
[TBL] [Abstract][Full Text] [Related]
33. A sodium-channel mutation causes isolated cardiac conduction disease.
Tan HL; Bink-Boelkens MT; Bezzina CR; Viswanathan PC; Beaufort-Krol GC; van Tintelen PJ; van den Berg MP; Wilde AA; Balser JR
Nature; 2001 Feb; 409(6823):1043-7. PubMed ID: 11234013
[TBL] [Abstract][Full Text] [Related]
34. A novel SCN5A mutation, F1344S, identified in a patient with Brugada syndrome and fever-induced ventricular fibrillation.
Keller DI; Huang H; Zhao J; Frank R; Suarez V; Delacrétaz E; Brink M; Osswald S; Schwick N; Chahine M
Cardiovasc Res; 2006 Jun; 70(3):521-9. PubMed ID: 16616735
[TBL] [Abstract][Full Text] [Related]
35. Sodium channel (dys)function and cardiac arrhythmias.
Remme CA; Bezzina CR
Cardiovasc Ther; 2010 Oct; 28(5):287-94. PubMed ID: 20645984
[TBL] [Abstract][Full Text] [Related]
36. Structure and function of splice variants of the cardiac voltage-gated sodium channel Na(v)1.5.
Schroeter A; Walzik S; Blechschmidt S; Haufe V; Benndorf K; Zimmer T
J Mol Cell Cardiol; 2010 Jul; 49(1):16-24. PubMed ID: 20398673
[TBL] [Abstract][Full Text] [Related]
37. Genetic Na+ channelopathies and sinus node dysfunction.
Lei M; Huang CL; Zhang Y
Prog Biophys Mol Biol; 2008; 98(2-3):171-8. PubMed ID: 19027778
[TBL] [Abstract][Full Text] [Related]
38. [Cardiac sodium channelopathy from bench to bedside].
Zhang YM; Zhou N
Zhonghua Er Ke Za Zhi; 2013 Nov; 51(11):874-7. PubMed ID: 24484568
[No Abstract] [Full Text] [Related]
39. Fever-induced life-threatening arrhythmias in children harboring an SCN5A mutation.
Chockalingam P; Rammeloo LA; Postema PG; Hruda J; Clur SA; Blom NA; Wilde AA
Pediatrics; 2011 Jan; 127(1):e239-44. PubMed ID: 21135007
[TBL] [Abstract][Full Text] [Related]
40. A novel mutation L619F in the cardiac Na+ channel SCN5A associated with long-QT syndrome (LQT3): a role for the I-II linker in inactivation gating.
Wehrens XH; Rossenbacker T; Jongbloed RJ; Gewillig M; Heidbüchel H; Doevendans PA; Vos MA; Wellens HJ; Kass RS
Hum Mutat; 2003 May; 21(5):552. PubMed ID: 12673799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
